Cerebrospinal fluid levels of insulin, leptin, and agouti‐related protein in relation to BMI in pregnant women. Issue 6 (30th April 2016)

• Record Type: Journal Article
• Authors: Gustavsson, Carolina; Andersson Hall, Ulrika; Pelanis, Aurimantas; Karlsson, Ove I.; Andersson, Louise; Svedin, Pernilla; Mallard, Carina; Myntti, Alexandra; Andreasson, Ulf; Zetterberg, Henrik; Blennow, Kaj; Holmäng, Agneta
• Is Part Of: Obesity. Volume 24:Issue 6(2016)
• Page Start: 1299
• Page End: 1304
• Publication Date: 2016-04-30
• Subjects: Obesity -- Periodicals; 616.398005
• DOI: 10.1002/oby.21502
• Languages: English
• ISSNs: 1930-7381

Abstract

Abstract : Objective: During pregnancy, metabolic interactions must be adapted, though neuroendocrine mechanisms for increased food intake are poorly understood. The objective of this study was to characterize differences in insulin, leptin, and agouti‐related protein (AgRP) levels in serum and cerebrospinal fluid (CSF) in pregnant women with normal weight (NW) and pregnant women with overweight (OW) or obesity (OB). Placenta as a source for increased peripheral AgRP levels during pregnancy was also investigated. Methods: Women were recruited at admission for elective cesarean section. Insulin, AgRP, and leptin were measured in serum and CSF from 30 NW, 25 OW, and 21 OB at term. Serum during pregnancy and placenta at term were collected for further AgRP analysis. Results: Immunohistology showed placental production of AgRP and serum AgRP levels increased throughout pregnancy. CSF AgRP, leptin, and insulin levels were higher in OW and OB than NW. Serum leptin and insulin levels were higher and AgRP lower in OB than NW. Conclusions: High serum AgRP levels might protect from the suppressive effects of leptin during pregnancy. Pregnant women with OB and OW might further be protected from the suppressive effect of leptin by high CSF AgRP levels. Evidence was found, for the first time, of human placental AgRP production mirrored by levels in the circulation.